Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Free Cash Flow (2016 - 2025)

InspireMD (NSPR) has 16 years of Free Cash Flow data on record, last reported at -$9.0 million in Q3 2025.

  • For Q3 2025, Free Cash Flow fell 46.41% year-over-year to -$9.0 million; the TTM value through Sep 2025 reached -$34.1 million, down 65.44%, while the annual FY2024 figure was -$23.3 million, 38.87% down from the prior year.
  • Free Cash Flow reached -$9.0 million in Q3 2025 per NSPR's latest filing, down from -$8.9 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$2.6 million in Q2 2021 and bottomed at -$9.2 million in Q1 2025.
  • Average Free Cash Flow over 5 years is -$5.1 million, with a median of -$4.4 million recorded in 2023.
  • Peak YoY movement for Free Cash Flow: grew 22.35% in 2023, then crashed 84.49% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$3.0 million in 2021, then dropped by 9.38% to -$3.3 million in 2022, then plummeted by 33.5% to -$4.4 million in 2023, then tumbled by 60.77% to -$7.1 million in 2024, then dropped by 26.92% to -$9.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were -$9.0 million in Q3 2025, -$8.9 million in Q2 2025, and -$9.2 million in Q1 2025.